Articles by Disease (Subacute Combined Degeneration)

Past, Present and Future Therapeutics for Cerebellar Ataxias

Journal: Current Neuropharmacology
Volume: 8
Page: 41-61
Author(s): D. Marmolino and M. Manto

Update on the Pharmacological Treatment of Alzheimers Disease

Journal: Current Neuropharmacology
Volume: 8
Page: 69-80
Author(s): Fadi Massoud and Serge Gauthier

A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists

Journal: Current Medicinal Chemistry
Volume: 17
Page: 504-516
Author(s): M. Munoz, M. Rosso and R. Covenas

Cell-Penetrating Peptide Technology to Deliver Chaperones and Associated Factors in Diseases and Basic Research

Journal: Current Pharmaceutical Biotechnology
Volume: 11
Page: 167-174
Author(s): Gunnar P.H. Dietz

Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders

Journal: Current Drug Targets
Volume: 11
Page: 111-121
Author(s): M. Mancuso, D. Orsucci, L. Volpi, V. Calsolaro, G. Siciliano, Antonino Spinelli, Carmen Correale, Hajnalka Szabo and Marco Montorsi

Experimental and Clinical Studies on Rifacinna® - The New Effective Antituberculous Drug (Review)

Journal: Recent Patents on Anti-Infective Drug Discovery
Volume: 5
Page: 76-90
Author(s): Dimova Velichka, Atanasova Ivana, Tomioka Haruaki, Sato Katsumasa, Reddy Venkata, Geeta Nadadhur, Daneluzzi Donna, Gangadharam Patisapu, Kantardjiev Todor, Dhople Arvind, Feshchenko Yurii, Yashina Ljudmila, Toumanov Andrei, Zhivkova Zvetana and Sano Chiaki

Articles by Disease (Subacute Combined Degeneration)

Past, Present and Future Therapeutics for Cerebellar Ataxias

Update on the Pharmacological Treatment of Alzheimers Disease

A New Frontier in the Treatment of Cancer: NK-1 Receptor Antagonists

Cell-Penetrating Peptide Technology to Deliver Chaperones and Associated Factors in Diseases and Basic Research

Coenzyme Q10 in Neuromuscular and Neurodegenerative Disorders

Experimental and Clinical Studies on Rifacinna® - The New Effective Antituberculous Drug (Review)

Cytopathological Mechanisms in Mitochondrial Disease

Targeting Matrix Metalloproteinases in Inflammatory Conditions

Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”

Mesenchymal Stem Cells: A Good Candidate for Restenosis Therapy?